Similar articles for PMID: 39054065

Year	Number of Results
2003	1
2004	1
2010	1
2011	2
2012	1
2013	1
2014	2
2016	4
2017	7
2018	4
2019	8
2020	13
2021	18
2022	13
2023	23
2024	13

1

A Strategic Guide to Improve and De-risk Vaccine Development: CEPI's CMC Framework.

S Aumlrnef Aumllt A, Eardley-Patel R, Magini D, Sonje V, Guzzi A, Hesselink R, Scotney M, Lazdins A, Chambard V, Vinnemeier C, Kromann I. S Aumlrnef Aumllt A, et al. PDA J Pharm Sci Technol. 2024 Jul 25:pdajpst.2023.012912. doi: 10.5731/pdajpst.2023.012912. Online ahead of print. PDA J Pharm Sci Technol. 2024. PMID: 39054065

2

CEPI: Driving Progress Toward Epidemic Preparedness and Response.

Gouglas D, Christodoulou M, Plotkin SA, Hatchett R. Gouglas D, et al. Epidemiol Rev. 2019 Jan 31;41(1):28-33. doi: 10.1093/epirev/mxz012. Epidemiol Rev. 2019. PMID: 31673694 Free PMC article. Review.

3

Finding equipoise: CEPI revises its equitable access policy.

Huneycutt B, Lurie N, Rotenberg S, Wilder R, Hatchett R. Huneycutt B, et al. Vaccine. 2020 Feb 24;38(9):2144-2148. doi: 10.1016/j.vaccine.2019.12.055. Epub 2020 Jan 28. Vaccine. 2020. PMID: 32005536 Free PMC article. Review.

4

Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need.

Cherian N, Bettis A, Deol A, Kumar A, Di Fabio JL, Chaudhari A, Yimer S, Fahim R, Endy T. Cherian N, et al. NPJ Vaccines. 2023 Aug 18;8(1):123. doi: 10.1038/s41541-023-00722-x. NPJ Vaccines. 2023. PMID: 37596253 Free PMC article. Review.

5

Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines.

Popkin ME, Goese M, Wilkinson D, Finnie S, Flanagan T, Campa C, Clinch A, Teasdale A, Lennard A, Cook G, Mohan G, Osborne MD. Popkin ME, et al. AAPS J. 2022 Sep 27;24(6):101. doi: 10.1208/s12248-022-00751-9. AAPS J. 2022. PMID: 36168002 Free PMC article. Review.

6

Unifying global efforts by CEPI's centralized laboratory network.

Azizi A, Bernasconi V. Azizi A, et al. Front Immunol. 2024 Apr 11;15:1404309. doi: 10.3389/fimmu.2024.1404309. eCollection 2024. Front Immunol. 2024. PMID: 38665918 Free PMC article. No abstract available.

7

Availability and use of Standards in vaccine development.

Avumegah MS, Mattiuzzo G, Särnefält A, Page M, Makar K, Lathey J, Kim J, Yimer SA, Craig D, Knezevic I, Bernasconi V, Kristiansen PA, Kromann I. Avumegah MS, et al. NPJ Vaccines. 2023 Jun 30;8(1):95. doi: 10.1038/s41541-023-00692-0. NPJ Vaccines. 2023. PMID: 37391580 Free PMC article. Review.

8

The Coalition for Epidemic Preparedness Innovations (CEPI) and the Partnerships of Equitable Vaccine Access.

Halabi S, Gostin LO, Aneja K, Nardi F, Gottschalk K, Monahan J. Halabi S, et al. J Law Med Ethics. 2023;51(2):234-246. doi: 10.1017/jme.2023.85. Epub 2023 Sep 1. J Law Med Ethics. 2023. PMID: 37655558 Free PMC article.

9

Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA).

Shivji R, Conocchia R, Korakianiti E, Jekerle V. Shivji R, et al. Vaccine. 2022 Sep 9;40(38):5539-5541. doi: 10.1016/j.vaccine.2022.06.058. Epub 2022 Jun 24. Vaccine. 2022. PMID: 35779964 Free PMC article.

10

Strengthening cancer control in the South Pacific through coalition-building: a co-design framework.

Hyatt A, Chan B, Moodie R, Varlow M, Bates C, Foliaki S, Palafox N, Burich S, Aranda S. Hyatt A, et al. Lancet Reg Health West Pac. 2023 Jan 13;33:100681. doi: 10.1016/j.lanwpc.2022.100681. eCollection 2023 Apr. Lancet Reg Health West Pac. 2023. PMID: 37181526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year